Cameron Durrant

Insider Reports History

Location
Califon, NJ
Signature
/s/ Henry Madrid, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cameron Durrant:

Company Role Class Num Shares Value Price $ Report Date Ownership
HUMANIGEN, INC Chief Executive Officer, Director Stock Option (Right to Buy) 808,906 $3,664,344 $4.53 27 Jul 2022 Direct

Insider Reports Filed by Cameron Durrant

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000121465922009383-durrant-cameron-2022-07-27 HUMANIGEN, INC 27 Jul 2022 1 $0 4 Chief Executive Officer, Director 29 Jul 2022, 18:30
/report/000121465922003623-durrant-cameron-2022-03-02 HUMANIGEN, INC 02 Mar 2022 1 +$93,600 4 Chief Executive Officer, Director 04 Mar 2022, 05:06
/report/000121465922000739-durrant-cameron-2022-01-12 HUMANIGEN, INC 12 Jan 2022 1 $0 4 Chief Executive Officer, Director 14 Jan 2022, 16:06
/report/000121465922000264-durrant-cameron-2021-12-31 HUMANIGEN, INC 31 Dec 2021 1 $0 4 Chief Executive Officer, Director 04 Jan 2022, 17:20
/report/000121465921012328-durrant-cameron-2021-11-23 HUMANIGEN, INC 23 Nov 2021 1 -$80,000 4 Chief Executive Officer, Director 26 Nov 2021, 16:15
/report/000121465921010215-durrant-cameron-2021-09-30 HUMANIGEN, INC 30 Sep 2021 1 $0 4 Chief Executive Officer, Director 04 Oct 2021, 20:07
/report/000121465921006640-durrant-cameron-2021-06-14 HUMANIGEN, INC 14 Jun 2021 5 -$1,680,934 4 Chief Executive Officer, Director 16 Jun 2021, 21:40